Invested by Europe: Why Biotech is Vital to Europe’s Economy as well as its Health

Biotechnology is one of Europe’s most important — and most
challenging — innovation sectors. From vaccines and drugs to
medical devices and digital medicine, biotech underpins Europe’s
health systems, competitiveness and economic
sovereignty. 


In this episode of Invested by Europe, Antoine
de Lachaux, head of the life science
and biotech unit at the European Investment Bank,
explains: 


What biotech means — from pharmaceuticals and
vaccines to medical devices and digital health 

Why life sciences are strategically important for
Europe 

Why biotech innovation takes time, carries high
risk and requires patient capital 

How Europe’s fragmented market makes scaling more difficult
than in the United States 

What the proposed Biotech Act could change for European
companies 

How the EIB supports the sector, including its early
investment in BioNTech 

Why artificial intelligence is set to accelerate drug
development, diagnostics and regulatory processes 



The conversation also looks at why Europe needs a truly European
investment ecosystem to help biotech companies grow to global
scale — and why this is a sector Europe cannot afford to
outsource.


Hosted on Acast. See acast.com/privacy for more information.